STOCK TITAN

IBEX Ltd COO David Martin Afdahl sells 28,319 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

IBEX Ltd’s Chief Operating Officer, David Martin Afdahl, exercised options to acquire 17,500 common shares at an exercise price of $12.75 and 10,819 common shares at $19.00 on November 16, 2026. He sold 28,319 common shares that day in a cashless exercise and same-day sale, at a weighted average price of $56.3538 per share. The sale involved multiple trades from $55.59 to $57.01 per share. No Rule 10b5-1 plan is reported.

Insider Afdahl David Martin
Role Chief Operating Officer
Sold 28,319 shs ($1.60M)
Approx. gross sale proceeds $1.60M
Approx. exercise cost $429K
Approx. pre-tax spread $1.17M
Share of Position Sold 16.8%
Type Security Shares Price Value
Exercise Stock Option (Right to Buy Common Shares) F2 17,500 $0.00 $0.00
Exercise Stock Option (Right to Buy Common Shares) F3 10,819 $0.00 $0.00
Exercise Common Shares 17,500 $12.75 $223K
Exercise Common Shares 10,819 $19.00 $206K
Sale Common Shares F1 28,319 $56.3538 $1.60M
Holdings After Transaction: Stock Option (Right to Buy Common Shares) — 0 options (Direct); Common Shares — 140,325 shares (Direct)
Holdings Before and After: Stock Option (Right to Buy Common Shares), 28,319 to 0 options (Direct); Common Shares, 140,325 to 140,325 shares (Direct)
Other Insiders: 6 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
  1. F1. Reflects a cashless exercise and same-day sale of shares. This transaction was executed in multiple trades at prices ranging from $55.59 to $57.01; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. F2. The shares subject to this option were fully vested and exercisable as of June 1, 2023.
  3. F3. The shares subject to this option were fully vested and exercisable as of August 1, 2022.
Option shares exercised 17,500 shares At an exercise price of $12.75 per share on November 16, 2026
Exercise price $12.75 per share For the option covering 17,500 shares exercised on November 16, 2026
Option shares exercised 10,819 shares At an exercise price of $19.00 per share on November 16, 2026
Exercise price $19.00 per share For the option covering 10,819 shares exercised on November 16, 2026
Common shares sold 28,319 shares Sale on November 16, 2026
Weighted average sale price $56.3538 per share Sale on November 16, 2026
Sale price range $55.59–$57.01 per share Multiple trades on November 16, 2026
cashless exercise financial
"Reflects a cashless exercise and same-day sale of shares"
A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.
weighted average sales price financial
"the price reported above reflects the weighted average sales price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IBEX shares did David Martin Afdahl sell, and at what price?

He sold 28,319 common shares on November 16, 2026, at a weighted average price of $56.3538 per share. The sale was executed in multiple trades at prices ranging from $55.59 to $57.01 per share.

When were David Martin Afdahl’s IBEX options fully vested and exercisable?

The option covering 17,500 shares was fully vested and exercisable as of June 1, 2023; the option covering 10,819 shares was fully vested and exercisable as of August 1, 2022.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Afdahl David Martin

(Last)(First)(Middle)
C/O IBEX LIMITED
1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)
WASHINGTON DISTRICT OF COLUMBIA 20006

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares11/16/2026M17,500A$12.75157,825D
Common Shares11/16/2026M10,819A$19168,644D
Common Shares11/16/2026S28,319D$56.3538(1)140,325D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy Common Shares)$12.7511/16/2026M17,500 (2)06/30/2030Common Shares17,500$00D
Stock Option (Right to Buy Common Shares)$1911/16/2026M10,819 (3)08/07/2030Common Shares10,819$00D
Explanation of Responses:
1. Reflects a cashless exercise and same-day sale of shares. This transaction was executed in multiple trades at prices ranging from $55.59 to $57.01; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2. The shares subject to this option were fully vested and exercisable as of June 1, 2023.
3. The shares subject to this option were fully vested and exercisable as of August 1, 2022.
Remarks:
Lisa Lenstrohm, Attorney-in-Fact11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading